Critical Path Public Private Partnerships Clinical Trials Optional
Agency: Food and Drug Administration
Assistance Listings: 93.103 -- Food and Drug Administration Research
Description
The FDA seeks an application to continue to maintain, manage existing consortia groups convened and established by the Critical Path Institute. This is a renewal of the cooperative agreement #5U18FD005320 as part of the Critical Path Initiative. This is in support of Critical Path Initiative introduced in Section 566 of the Federal Food, Drug, and Cosmetic Act. This includes developing innovative, collaborative projects in research, education, and outreach for fostering drug product innovation, enabling the acceleration of development, manufacturing, and translational therapeutics, enhancing safety, efficacy, quality, and performance. This funding opportunity will provide support, depending on availability of FDA funding.
Eligibility
Eligible applicants
Miscellaneous
- Other
Additional information
Grantor contact information
Description
terrin.brown@fda.hhs.gov
Documents
No documents are currently available.
Link to additional information
--
Forecasted
Estimated Post Date:
--
Estimated Application Due Date:
--
Estimated Due Date Description:
Not available
Estimated Award Date:
--
Estimated Project Start Date:
--
Fiscal Year:
2024
Award
$--
Program Funding
1
Expected awards
$20,000,000
Award Minimum
$20,000,000
Award Maximum
Funding opportunity number:
FOR-FD-24-012
Cost sharing or matching requirement:
Funding instrument type:
Cooperative agreement
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Food and nutrition
Consumer protection
Agriculture
Category Explanation:
History
Version:
2
Forecast posted date:
November 30, 2023
Archive date:
--
